Instituto do Câncer Brasil- IC Brasil
- Company typePrivate
- Founded-
- Headquarters—
- Headcount11–50
- GTM typeB2C
- OfferingServices
Instituto do Câncer Brasil- IC Brasil firmographics
Firmographics- Name
- Instituto do Câncer Brasil- IC Brasil
- Website
- https://institutodocancerbrasil.com.br
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Instituto do Câncer Brasil- IC Brasil industry classification
Industry- Product category
- Oncology Healthcare Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industry
- Multilateral Global Health Agencies (UN/IFIs) (HLAJAKAA)
Keywords
Instituto do Câncer Brasil- IC Brasil business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Others
Instituto do Câncer Brasil- IC Brasil product offering
Product offeringCore offering
Based on the company name "Instituto do Câncer Brasil" (Cancer Institute Brazil), the entity appears intended to operate in the oncology domain in Brazil. No specific products, services, clinical programs, or operational details are evidenced in the source material, which consists solely of a website loading/verification page with no substantive content.
Differentiator
Problem solved
Functional benefit
Companies that use Instituto do Câncer Brasil- IC Brasil
Customer profileIdeal customer profiles1 record
Instituto do Câncer Brasil- IC Brasil technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Instituto do Câncer Brasil- IC Brasil competitors and assessment
Company assessmentDirect peers
- Oncoclínicas: Brazil's largest oncology clinic group, providing medical oncology, hematology, and infusion services. Comparable as a Brazilian outpatient oncology services operator.
- A.C. Camargo Cancer Center: One of Brazil's most recognized cancer specialty hospitals in São Paulo. Directly comparable as a Brazil-based, cancer-focused specialty institute offering diagnosis, treatment, and research.
- Hospital de Câncer de Barretos: Large Brazilian cancer hospital network known for high-volume oncology care. Comparable as a dedicated oncology institution serving the Brazilian market.
- Grupo Oncologia D'Or: Specialized oncology provider affiliated with Rede D'Or focused on medical oncology and infusion services. Comparable as a Brazil-based dedicated cancer services operator.
Broad incumbents
- Hospital Israelita Albert Einstein: Large Brazilian hospital system with a dedicated oncology center. Comparable as an incumbent providing comprehensive cancer care in Brazil at greater scale and broader scope.
- Rede D'Or São Luiz: Brazil's largest private hospital network with significant oncology service lines. Comparable as a large incumbent operating cancer care across multiple Brazilian geographies.
- Hospital Sírio-Libanês: Premium São Paulo hospital with a strong oncology program. Comparable as a broad incumbent offering specialty cancer care alongside other services.
Market position
Strengths2 records
Weaknesses2 records
Key risks3 records
Key highlights1 record
Customer concentration
Instituto do Câncer Brasil- IC Brasil social profiles
Digital presenceInstituto do Câncer Brasil- IC Brasil financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto do Câncer Brasil- IC Brasil leadership team
Management profileNumber of profiles
Instituto do Câncer Brasil- IC Brasil funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto do Câncer Brasil- IC Brasil M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto do Câncer Brasil- IC Brasil
What does Instituto do Câncer Brasil- IC Brasil do?
Based on the company name "Instituto do Câncer Brasil" (Cancer Institute Brazil), the entity appears intended to operate in the oncology domain in Brazil. No specific products, services, clinical programs, or operational details are evidenced in the source material, which consists solely of a website loading/verification page with no substantive content.
When was Instituto do Câncer Brasil- IC Brasil founded?
Instituto do Câncer Brasil- IC Brasil was founded in -1. It employs 11 to 50 people.
Who are Instituto do Câncer Brasil- IC Brasil's main competitors?
Direct peers on record are Oncoclínicas, A.C. Camargo Cancer Center, Hospital de Câncer de Barretos and Grupo Oncologia D'Or. Broad incumbents are Hospital Israelita Albert Einstein, Rede D'Or São Luiz and Hospital Sírio-Libanês.
Does Instituto do Câncer Brasil- IC Brasil have an API?
No public API is recorded for Instituto do Câncer Brasil- IC Brasil.
What industry is Instituto do Câncer Brasil- IC Brasil in?
Instituto do Câncer Brasil- IC Brasil's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAJAKAA, Multilateral Global Health Agencies (UN/IFIs). Its NAICS code is 621511 and its SIC code is 8011.